Inovio Pharmaceuticals Inc (INO) — Cash Flow-to-Debt Ratio
Inovio Pharmaceuticals Inc (INO) has a Cash Flow-to-Debt Ratio of -0.28x as of September 2025, meaning its operating cash flow of $-21.57 Million could theoretically repay 0% of its total liabilities ($77.11 Million) in one year. Explore investment intensity of Inovio Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Inovio Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Inovio Pharmaceuticals Inc across 27 annual periods. Also explore Inovio Pharmaceuticals Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Inovio Pharmaceuticals Inc (1998–2024)
Year-by-year debt coverage analysis for Inovio Pharmaceuticals Inc. For market capitalisation and broader financial context, see INO company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.33x | $-104.08 Million | $44.69 Million | ▼ -0.4% |
| 2023 | -2.32x | $-124.37 Million | $53.60 Million | ▼ -35.4% |
| 2022 | -1.71x | $-216.22 Million | $126.17 Million | ▲ +23.5% |
| 2021 | -2.24x | $-215.71 Million | $96.27 Million | ▲ +1.0% |
| 2020 | -2.26x | $-177.98 Million | $78.63 Million | ▼ -220.5% |
| 2019 | -0.71x | $-97.85 Million | $138.55 Million | ▲ +57.7% |
| 2018 | -1.67x | $-73.55 Million | $44.08 Million | ▼ -18.1% |
| 2017 | -1.41x | $-63.21 Million | $44.75 Million | ▼ -13.6% |
| 2016 | -1.24x | $-62.56 Million | $50.33 Million | ▼ -278.8% |
| 2015 | -0.33x | $-12.44 Million | $37.91 Million | ▲ +77.7% |
| 2014 | -1.47x | $-29.82 Million | $20.25 Million | ▼ -238.8% |
| 2013 | -0.43x | $-15.38 Million | $35.38 Million | ▲ +80.0% |
| 2012 | -2.17x | $-22.31 Million | $10.28 Million | ▼ -45.5% |
| 2011 | -1.49x | $-19.76 Million | $13.24 Million | ▼ -12.0% |
| 2010 | -1.33x | $-11.94 Million | $8.97 Million | ▼ -83.9% |
| 2009 | -0.72x | $-14.08 Million | $19.44 Million | ▼ -29.4% |
| 2008 | -0.56x | $-11.13 Million | $19.88 Million | ▲ +57.5% |
| 2007 | -1.32x | $-11.51 Million | $8.74 Million | ▼ -132.8% |
| 2006 | -0.57x | $-7.04 Million | $12.45 Million | ▲ +74.7% |
| 2005 | -2.24x | $-12.34 Million | $5.51 Million | ▼ -77.9% |
| 2004 | -1.26x | $-6.80 Million | $5.40 Million | ▲ +45.9% |
| 2003 | -2.33x | $-2.75 Million | $1.18 Million | ▲ +20.5% |
| 2002 | -2.93x | $-4.96 Million | $1.69 Million | ▲ +41.6% |
| 2001 | -5.01x | $-8.37 Million | $1.67 Million | ▲ +9.0% |
| 2000 | -5.51x | $-8.79 Million | $1.60 Million | ▼ -90.7% |
| 1999 | -2.89x | $-6.30 Million | $2.18 Million | ▲ +31.2% |
| 1998 | -4.20x | $-6.30 Million | $1.50 Million | — |